Literature DB >> 9337875

Characterization of iduronate sulphatase mutants affecting N-glycosylation sites and the cysteine-84 residue.

G Millat1, R Froissart, I Maire, D Bozon.   

Abstract

Iduronate sulphatase (IDS) is responsible for mucopolysaccharidosis type II, a rare recessive X-linked lysosomal storage disease. The aim of this work was to evaluate the functional importance of each N-glycosylation site, and of the cysteine-84 residue. IDS mutant cDNAs, lacking one of the eight potential N-glycosylation sites, were expressed in COS cells. Although each of the potential sites was used, none of the eight glycosylation sites appeared to be essential for lysosomal targeting. Another important sulphatase co- or post-translational modification for generating catalytic activity involves the conversion of a cysteine residue surrounded by a conserved sequence C-X-P-S-R into a 2-amino-3-oxopropionic acid residue [Schmidt, Selmer, Ingendoh and von Figura (1995) Cell 82, 271-278]. This conserved cysteine, located at amino acid position 84 in IDS, was replaced either by an alanine (C84A) or by a threonine (C84T) using site-directed mutagenesis. C84A and C84T mutant cDNAs were expressed either in COS cells or in human lymphoblastoid cells deleted for the IDS gene. C84A had a drastic effect both for IDS processing and for catalytic activity. The C84T mutation produced a small amount of mature forms but also abolished enzyme activity, confirming that the cysteine residue at position 84 is required for IDS activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9337875      PMCID: PMC1218661          DOI: 10.1042/bj3260243

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  14 in total

1.  Analysis of the glycosylation and phosphorylation of the lysosomal enzyme, beta-hexosaminidase B, by site-directed mutagenesis.

Authors:  S Sonderfeld-Fresko; R L Proia
Journal:  J Biol Chem       Date:  1989-05-05       Impact factor: 5.157

2.  The role of glycosylation and phosphorylation in the expression of active human beta-glucuronidase.

Authors:  J M Shipley; J H Grubb; W S Sly
Journal:  J Biol Chem       Date:  1993-06-05       Impact factor: 5.157

3.  Hunter syndrome: gene deletions and rearrangements.

Authors:  R Froissart; J L Blond; I Maire; P Guibaud; J J Hopwood; M Mathieu; D Bozon
Journal:  Hum Mutat       Date:  1993       Impact factor: 4.878

4.  Directional antisense and sense cDNA cloning using Epstein-Barr virus episomal expression vectors.

Authors:  R K Groger; D M Morrow; M L Tykocinski
Journal:  Gene       Date:  1989-09-30       Impact factor: 3.688

5.  Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA.

Authors:  P J Wilson; C P Morris; D S Anson; T Occhiodoro; J Bielicki; P R Clements; J J Hopwood
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

6.  Biochemical variability of arylsulphatases -A, -B and -C in cultured fibroblasts from patients with multiple sulphatase deficiency.

Authors:  P L Chang; N E Rosa; S R Ballantyne; R G Davidson
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

7.  Analysis of the glycosylation and phosphorylation of the alpha-subunit of the lysosomal enzyme, beta-hexosaminidase A, by site-directed mutagenesis.

Authors:  G Weitz; R L Proia
Journal:  J Biol Chem       Date:  1992-05-15       Impact factor: 5.157

8.  Human lysosomal alpha-glucosidase: functional characterization of the glycosylation sites.

Authors:  M M Hermans; H A Wisselaar; M A Kroos; B A Oostra; A J Reuser
Journal:  Biochem J       Date:  1993-02-01       Impact factor: 3.857

9.  Multiple sulfatase deficiency: catalytically inactive sulfatases are expressed from retrovirally introduced sulfatase cDNAs.

Authors:  W Rommerskirch; K von Figura
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  12 in total

1.  Expression studies of mutations underlying Taiwanese Hunter syndrome (mucopolysaccharidosis type II).

Authors:  Jui-Hung Chang; Shuan-Pei Lin; Shu-Chuan Lin; Kai-Li Tseng; Chia-Ling Li; Chih-Kuang Chuang; Guey-Jen Lee-Chen
Journal:  Hum Genet       Date:  2004-12-22       Impact factor: 4.132

Review 2.  Is genotype determination useful in predicting the clinical phenotype in lysosomal storage diseases?

Authors:  I Maire
Journal:  J Inherit Metab Dis       Date:  2001       Impact factor: 4.982

3.  Deep Genotyping of the IDS Gene in Colombian Patients with Hunter Syndrome.

Authors:  Johanna Galvis; Jannet González; Alfredo Uribe; Harvy Velasco
Journal:  JIMD Rep       Date:  2015-02-15

4.  Low-scale expression and purification of an active putative iduronate 2-sulfate sulfatase-Like enzyme from Escherichia coli K12.

Authors:  Edwin David Morales-Álvarez; Claudia Marcela Rivera-Hoyos; Angélica María Baena-Moncada; Patricia Landázuri; Raúl A Poutou-Piñales; Homero Sáenz-Suárez; Luis A Barrera; Olga Y Echeverri-Peña
Journal:  J Microbiol       Date:  2013-04-27       Impact factor: 3.422

5.  A biochemical and physicochemical comparison of two recombinant enzymes used for enzyme replacement therapies of hunter syndrome.

Authors:  Yo Kyung Chung; Young Bae Sohn; Jong Mun Sohn; Jieun Lee; Mi Sun Chang; Younghee Kwun; Chi Hwa Kim; Jin Young Lee; Yeon Joo Yook; Ah-Ra Ko; Dong-Kyu Jin
Journal:  Glycoconj J       Date:  2014-04-30       Impact factor: 2.916

6.  Analysis of normal and mutant iduronate-2-sulphatase conformation.

Authors:  Emma Parkinson-Lawrence; Christopher Turner; John Hopwood; Doug Brooks
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

7.  Effect of Hunter disease (mucopolysaccharidosis type II) mutations on molecular phenotypes of iduronate-2-sulfatase: enzymatic activity, protein processing and structural analysis.

Authors:  K Sukegawa-Hayasaka; Z Kato; H Nakamura; S Tomatsu; T Fukao; K Kuwata; T Orii; N Kondo
Journal:  J Inherit Metab Dis       Date:  2006-11-07       Impact factor: 4.982

8.  Overexpression of inactive arylsulphatase mutants and in vitro activation by light-dependent oxidation with vanadate.

Authors:  Terri M Christianson; Chris M Starr; Todd C Zankel
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

9.  Comparative study of idursulfase beta and idursulfase in vitro and in vivo.

Authors:  Chihwa Kim; Jinwook Seo; Yokyung Chung; Hyi-Jeong Ji; Jaehyeon Lee; Jongmun Sohn; Byoungju Lee; Eui-Cheol Jo
Journal:  J Hum Genet       Date:  2016-11-10       Impact factor: 3.172

10.  Ancestral lysosomal enzymes with increased activity harbor therapeutic potential for treatment of Hunter syndrome.

Authors:  Natalie M Hendrikse; Anna Sandegren; Tommy Andersson; Jenny Blomqvist; Åsa Makower; Dominik Possner; Chao Su; Niklas Thalén; Agneta Tjernberg; Ulrica Westermark; Johan Rockberg; Stefan Svensson Gelius; Per-Olof Syrén; Erik Nordling
Journal:  iScience       Date:  2021-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.